Overview

Rifaximin Use in Severe Alcoholic Hepatitis

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This study aimed to investigate the effect of decontamination by rifaximin in severe alcoholic hepatitis patients. Patients who take corticosteroid or pentoxifylline will be randomly allocated to rifaximin group or control group.

Phase:

Phase 3

Details

Lead Sponsor:

Saint Vincent's Hospital, Korea

Treatments:

Pentoxifylline
Rifamycins
Rifaximin